Novel 1-benzhydryl piperazine scaffold-based HDAC inhibitor b7 induces synergistic antiproliferative effect with vemurafenib in colorectal cancer cells harboring BRAF mutation.

18780261, 2025, S1, Downloaded from https://febs.onlinelibrary.wiley.com/doi/10.1002/1878-0261.70070. By Readcube (Labtiva Inc.), Wiley Online Library on [02/07/2025]. See the Terms and Conditions (https://onlinelibrary.wiley.com/ terms-and-conditions) on Wiley Online Library for rules of use; OA articles are governed by the applicable Creative Commons License 18780261, 2025, S1, Downloaded from https://febs.onlinelibrary.wiley.com/doi/10.1002/1878-0261.70070. By Readcube (Labtiva Inc.), Wiley Online Library on [02/07/2025]. See the Terms and Conditions (https://onlinelibrary.wiley.com/ terms-and-conditions) on Wiley Online Library for rules of use; OA articles are governed by the applicable Creative Commons License 18780261, 2025, S1, Downloaded from https://febs.onlinelibrary.wiley.com/doi/10.1002/1878-0261.70070. By Readcube (Labtiva Inc.), Wiley Online Library on [02/07/2025]. See the Terms and Conditions (https://onlinelibrary.wiley.com/ terms-and-conditions) on Wiley Online Library for rules of use; OA articles are governed by the applicable Creative Commons License